ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
Dow Jones
38,711.29
0.00%
US Dollar vs MXN
17.64605
-0.96%
Brent Oil
77.805
0.90%
Bitcoin
70,837.54
0.30%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
05/06/202407:13Business WireTexas Methodist Foundation's Grants Ministry Awards $900,000 to 40 Churches and Nonprofits Across Texas and New Mexico
05/06/202407:12CointelegraphUAE central bank approves licensing system for stablecoinsCOIN:BTCUSDBitcoin
05/06/202407:12Alliance NewsAlliance NewsFOREX MARKET: Dollar stable ahead of BoC, ECB interest rate decisions
05/06/202407:12Business WireRecurly Lifecycle Engagement Empowers Brands to Meet Subscribers Where They Are, Transforming Subscriber Growth and Fueling In-App Experiences
05/06/202407:12PR Newswire (US)Zhihu Inc. Appoints New Chief Technology OfficerNYSE:ZHZhihu Inc
05/06/202407:11GlobeNewswire Inc.Launch of Beacon Endowment Solutions
05/06/202407:11PR Newswire (US)Myrtelle Announces that the FDA has selected rAAV-Olig001-ASPA Gene Therapy Candidate for the treatment of Canavan Disease for the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) Pilot Program
05/06/202407:11PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NFT
05/06/202407:10Business WireFairway Private Equity & Venture Capital Opportunities Fund Announces First Quarter Results
05/06/202407:10PR Newswire (US)2024 ReturnOnLeadership Ranking Released by Indiggo in Partnership with Fortune
05/06/202407:10PR Newswire (US)Adams Resources & Energy, Inc. to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference on June 13th in New York, NYAMEX:AEAdams Resources and Energy Inc
05/06/202407:10PR Newswire (US)ONE Funds and Bow River Capital Announce Joint Venture Led by Defense Technology Veterans
05/06/202407:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]AMEX:VZLAVizsla Silver Corporation
05/06/202407:09PR Newswire (US)L+R Launches Emerging Technology Accelerator Program with Apple Vision Pro for SMBs and Enterprises
05/06/202407:09PR Newswire (US)DataOps.live Named Snowflake Data Cloud Product Growth Partner of the Year
05/06/202407:08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:HPEHewlett Packard Enterprise Company
05/06/202407:08Business WireGran Centenario Honors Founder and Tequila Legend Lázaro Gallardo with U.S. Launch of Gran Centenario Gallardo
05/06/202407:08PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - NFT
05/06/202407:07GlobeNewswire Inc.Bull Run Bets: Revolutionizing Online Casino Gaming with AI Integration
05/06/202407:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:APAmpco Pittsburgh Corp
05/06/202407:07PR Newswire (US)TOPIX Pharmaceuticals, Inc. Partners with the University of Minnesota, Center for Drug Design to Develop Groundbreaking ProteXidine Molecule
05/06/202407:06PR Newswire (US)ZM TRUCKS SECURES 900-UNIT INITIAL ORDER FROM EXCLUSIVE DISTRIBUTOR 32GROUP
05/06/202407:06PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - GLDNTSXV:GLDNGolden Ridge Resources Ltd
05/06/202407:05CointelegraphPrivate firms to join global central bank CBDC projectCOIN:BTCUSDBitcoin
05/06/202407:05Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SONMSonim Technologies Inc
05/06/202407:05Business WireAlliant Insurance Services Acquires Direct-to-Consumer ACA Agency Assured Health Group
05/06/202407:05Business WireSipWithMe Coffee Amenity Now Available in Most Major U.S. Metros
05/06/202407:05GlobeNewswire Inc.Marathon Digital Holdings Announces Bitcoin Production and Mining Operation Updates for May 2024NASDAQ:MARAMarathon Digital Holdings Inc
05/06/202407:05GlobeNewswire Inc.Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development ProgramsNASDAQ:IKTInhibikase Therapeutics Inc
05/06/202407:05Business WireSPAR Group Enters into Letter of Intent to go Private with Highwire CapitalNASDAQ:SGRPSpar Group Inc

Su Consulta Reciente

EU
EZWTR
EN CDP W EZ EW D5 PERCENT
NASDAQ
BCTG
BCTG Acquisition
TKOK
EOSETH
EOS
TSX
PAAS
Pan American Silver
ASX
AKP
Audio Pixels
LSE
QJ32
Morg.st.b.v 26
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados